BIO vs GMED
Bio-Rad Laboratories Inc · Globus Medical
Relative return (rebased to 100)
Key stats
| Metric | BIO | GMED |
|---|---|---|
| Price | $381.00 | $74.52 |
| Market Cap | $10.54B | $10.01B |
| P/E | 13.87 | 18.60 |
| P/B | 1.47 | 2.10 |
| P/S | 4.08 | 3.40 |
| ROE | 10.6% | 11.3% |
| Net Margin | 29.4% | 18.3% |
| Gross Margin | 51.9% | 34.7% |
| Revenue Growth | 0.7% | 16.7% |
| Dividend Yield | — | — |
| EPS | $27.46 | $4.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.